| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.005 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.46 | 0.005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |